2022

1. Haixia Long, Qingzhu Jia, Liuyang Wang, Wenfeng Fang, Zhongyu Wang, Tao Jiang, Fei Zhou, Zheng Jin, Jiani Huang, Li Zhou, Chunyan Hu, Xinxin Wang, Jin Zhang, Yujie Ba, Yujie Gong, Xianghua Zeng, Dong Zeng, Xingxing Su, Peter B. Alexander, Li Wang, Limei Wang, Yisong Y. Wan, Xiao-Fan Wang, Li Zhang, Qi-Jing Li, Bo Zhu ( 2022) Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy.
Cancer Cell 40, 674-693, June 13, 2022 DOI:https://doi.org/10.1016/j.ccell.2022.04.018

2. Shuhang Wang, Kun Chen, Yale Jiang, Guo Zhao, Caie Wang, Hong Fang, Qiyu Tang, Chao Sun, Liang Zhang, Haiyang Wu, Li-Feng Zhang, Ning Li Breaking boundaries: current progress of anticancer NK cell-based drug development
Drug Discovery Today, PII: S1359-6446(22)00429-9 DOI: https://doi.org/10.1016/j.drudis.2022.103436

Reference: DRUDIS 103436

关于天科雅

研究与发展

产品及临床

新闻与媒体

招贤纳士

联系我们